Evidence map›Paper›PMID 42404799›Full record

ArticleFrontiers in microbiology2026

Linking wet-lab and genomic approaches for reliable detection of carbapenemase-producing

K A Werner, V Bajić, C Blumenscheit, D Baum, D Desirò, S Sedaghatjoo, J Barthelmes, A K Liebschner, C Förster, S Fuchs and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

K A WernerMicrobiological Risks (II 1.4), German Environment Agency, Berlin, Germany.
V BajićGenome Competence Center, Robert Koch Institute, Berlin, Germany.
C BlumenscheitGenome Competence Center, Robert Koch Institute, Berlin, Germany.
D BaumMicrobiological Risks (II 1.4), German Environment Agency, Berlin, Germany.
D DesiròGenome Competence Center, Robert Koch Institute, Berlin, Germany.
S SedaghatjooGenome Competence Center, Robert Koch Institute, Berlin, Germany.
J BarthelmesMicrobiological Risks (II 1.4), German Environment Agency, Berlin, Germany.
A K LiebschnerMicrobiological Risks (II 1.4), German Environment Agency, Berlin, Germany.
C FörsterMicrobiology of Drinking Water and Swimming Pool Water (II 3.5), German Enviornment Agency, Berlin, Germany.
S FuchsGenome Competence Center, Robert Koch Institute, Berlin, Germany.
S A WolfGenome Competence Center, Robert Koch Institute, Berlin, Germany.
A BetheMicrobiological Risks (II 1.4), German Environment Agency, Berlin, Germany.
M HölzerGenome Competence Center, Robert Koch Institute, Berlin, Germany.
B WaltherMicrobiological Risks (II 1.4), German Environment Agency, Berlin, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The World Health Organization (WHO) has designated carbapenemase-producing

Indexed as

antimicrobial resistance (AMR)Carbapenemase-producing Klebsiella pneumoniaeESBL-E. coliEscherichia colimonitoringsurveillancewastewaterwhole genome sequencing (WGS)

Identifiers

PMID42404799
PMCPMC13328271

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.